06/10/2026 | Press release | Distributed by Public on 06/10/2026 03:27
Research Highlights:
Embargoed until 4 a.m. CT/5 a.m. ET Wednesday, June 10, 2026
DALLAS, June 10, 2026 - Numerous types of cardiovascular disease and CVD risk factors were linked to a higher risk of Alzheimer's disease, with low blood pressure showing the strongest connection, according to a new analysis published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.
"By examining different types of heart disease individually, we identified which adults with heart disease might have the highest risk for cognitive decline. This highlights the importance of optimal cardiovascular health to possibly prevent Alzheimer's disease," said Aili Toyli, B.S., lead author of the study and a student at Michigan Technological University in Houghton, Michigan.
Cardiovascular disease is a group of conditions that affect the heart and blood vessels throughout the body including the brain, such as coronary heart disease, stroke, heart failure, irregular heartbeat (atrial fibrillation) and risk factors, such as high or low blood pressure and Type 2 diabetes. Alzheimer's disease is the most common type of dementia, which slowly impairs memory, thinking and cognitive function. When there is inadequate blood flow to the brain, the reduced oxygen and nutrients create an environment that can foster accumulation of Alzheimer's-related proteins in the brain, such as amyloid beta and tau.
The study's findings indicate that many heart and blood vessel conditions - particularly those affecting blood flow - are strongly linked to brain health and Alzheimer's disease. While high blood pressure, Type 2 diabetes, obesity and smoking are independent risk factors for both cardiovascular disease and Alzheimer's disease, risk factors, particularly conditions like hypertension, can cause damage to blood vessels (vascular disease) and can lead to cognitive decline.
This study provides new details by analyzing health records for nearly 800,000 adults from 2 databases in the U.K. and the U.S. Specifically, types of heart and blood vessel conditions were individually examined rather than looking at them as a whole group, and then various subgroups were evaluated against the participants diagnosed with Alzheimer's disease at a single point in time over the study period.
What are the key findings of the analysis?
"Compared to hypertension, hypotension receives a lot less attention overall, which likely leads to less data and less research focus. Detailed research is needed to understand the biological mechanisms that might be behind the links between Alzheimer's and CVD. Once we determine the specific pathway that connects them, we may be able to intervene and break the chain before Alzheimer's develops," said Toyli.
"We've known for a long time that high blood pressure can have damaging long-term effects on the brain," said Elisabeth Marsh, M.D., FAHA, chair of the American Heart Association's 2026 Scientific Statement Brain Health Across the Lifespan.
"This study shows us that blood pressure can also become a problem when it is too low for long periods of time. The brain needs blood to get the oxygen and nutrients it needs to function properly. While science is beginning to understand the mechanisms that lead to neurodegeneration and cognitive decline as people age, it's not surprising that low blood pressure leads to dysfunction in the brain because the brain is not getting what it needs."
Marsh, who was not involved in this research, is a professor of neurology and associate director of the neurology residency program at The Johns Hopkins University School of Medicine and director of the Stroke Center at Johns Hopkins Bayview Medical Center in Baltimore.
To help achieve optimal heart health and reduce risk of cardiovascular diseases, the Associations' Life's Essential 8 metrics measure ideal heart and brain health based on an individual's physical activity, diet, smoking status, sleep habits, body mass index, blood pressure, cholesterol and blood sugar.
What are the study details, background and design?
Co-authors, disclosures and funding sources are listed in the manuscript.
Studies published in the American Heart Association's scientific journals are peer-reviewed. The statements and conclusions in each manuscript are solely those of the study authors and do not necessarily reflect the Association's policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives more than 85% of its revenue from sources other than corporations. These sources include contributions from individuals, foundations and estates, as well as investment earnings and revenue from the sale of our educational materials. Corporations (including pharmaceutical, device manufacturers and other companies) also make donations to the Association. The Association has strict policies to prevent any donations from influencing its science content and policy positions. Overall financial information is available here.
Additional Resources:
###
About the American Heart Association
The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public's health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1.
For Media Inquiries and AHA/ASA Expert Perspective: 214-706-1173
Kelsey Beveridge: [email protected]
For Public Inquiries: 1-800-AHA-USA1 (242-8721)
heart.org and stroke.org